Header Logo
Last Name

Araya Puwanant, M.D.

TitleAssistant Professor
InstitutionWake Forest School of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse awards and honors
    2011 - 2013MDA Clinical Research Training Award, University of Rochester
    2016NINDS Clinical Trial Methodology Course , NINDS

    Collapse Research 
    Collapse research activities and funding
    MDA480577     (Araya Puwanant)Feb 1, 2017 - Jul 30, 2020
    Muscular Dystrophy Association (MDA)
    Regional Body Composition and Clinical Endpoints in Myotonic Dystrophy
    Role Description: The major goal of this longitudinal study is to identify sensitive endpoints for progressive muscle weakness and atrophy in myotonic dystrophy.
    Role: PI

    NCTIC Pilot Grant     (Bushnell/Milligan)Dec 1, 2019 - Dec 31, 2020
    Wake Forest Neuroscience Clinical Trials and Innovation Center (NCTIC)
    Brain Structure and Cognitive Endpoints in Myotonic Dystrophy Type 2 (BRACE-MD2)
    Role Description: The focus of this program is to help foster junior investigators to develop new translational research projects with the strategic focus area of neuroscience that will lead to extramural funding support
    Role: Pilot Grant Awardee

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Heatwole C, Luebbe E, Rosero S, Eichinger K, Martens W, Hilbert J, Dekdebrun J, Dilek N, Zizzi C, Johnson N, Puwanant A, Tawil R, Schifitto G, Beck CA, Richeson JF, Zareba W, Thornton C, McDermott MP, Moxley R. Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial. Neurology. 2021 01 12; 96(2):e228-e240. PMID: 33046619.
      View in: PubMed
    2. Puwanant A, Isfort M, Lacomis D, Živkovic SA. Clinical spectrum of neuromuscular complications after immune checkpoint inhibition. Neuromuscul Disord. 2019 02; 29(2):127-133. PMID: 30638612.
      View in: PubMed
    3. Lacomis D, Puwanant A. What is in the Neuromuscular Junction Literature? J Clin Neuromuscul Dis. 2018 Dec; 20(2):76-84. PMID: 30439753.
      View in: PubMed
    4. Simmons DB, Lanning J, Cleland JC, Puwanant A, Twydell PT, Griggs RC, Tawil R, Logigian EL. Long Exercise Test in Periodic Paralysis: A Bayesian Analysis. Muscle Nerve. 2019 01; 59(1):47-54. PMID: 29752813.
      View in: PubMed
    5. Gonzalez NL, Puwanant A, Lu A, Marks SM, Živkovic SA. Myasthenia triggered by immune checkpoint inhibitors: New case and literature review. Neuromuscul Disord. 2017 Mar; 27(3):266-268. PMID: 28109638.
      View in: PubMed
    6. Harada Y, Puwanant A, Herrmann DN. Hereditary Neuropathy With Liability to Pressure Palsies: Diverse Phenotypes in Childhood. J Clin Neuromuscul Dis. 2016 Dec; 18(2):79-83. PMID: 27861220.
      View in: PubMed
    7. Heatwole C, Bode R, Johnson NE, Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, Mcdermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT. Myotonic dystrophy health index: Correlations with clinical tests and patient function. Muscle Nerve. 2016 Feb; 53(2):183-90. PMID: 26044513.
      View in: PubMed
    8. Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, Pandya S, Dekdebrun J, Heatwole CR, McDermott MP, Chen T, Cline M, Tawil R, Osborne RJ, Wheeler TM, Swanson MS, Moxley RT, Thornton CA. Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol. 2013 Dec; 74(6):862-72. PMID: 23929620.
      View in: PubMed
    9. Puwanant A, Herrmann DN. Multifocal acquired demyelinating sensory and motor neuropathy. Neurology. 2012 Oct 16; 79(16):1742. PMID: 23071167.
      View in: PubMed
    10. Murphy SM, Puwanant A, Griggs RC. Unintended effects of orphan product designation for rare neurological diseases. Ann Neurol. 2012 Oct; 72(4):481-90. PMID: 23109143.
      View in: PubMed
    11. Puwanant A, Evangelisti SM, Griggs RC. Treating the chief complaint: hand rejuvenation for Hirayama disease. Neurology. 2011 Jul 12; 77(2):190-1. PMID: 21715710.
      View in: PubMed
    12. Puwanant A, Ruff RL. INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis. Muscle Nerve. 2010 Sep; 42(3):315-27. PMID: 20589886.
      View in: PubMed
    13. Imerman KW, Miles JD, Park I, Puwanant A, Daroff RB, Qureshi S. Highlights from International Meetings: American Academy of Neurology AAN 61st Annual Meeting, Seattle, April 25th - May 2, 2009. Neurosciences (Riyadh). 2009 Jul; 14(3):310-3. PMID: 21048644.
      View in: PubMed
    14. Koubeissi MZ, Puwanant A, Jehi L, Alshekhlee A. In-hospital complications of epilepsy surgery: a six-year nationwide experience. Br J Neurosurg. 2009; 23(5):524-9. PMID: 19718552.
      View in: PubMed
    15. Kusner LL, Puwanant A, Kaminski HJ. Ocular myasthenia: diagnosis, treatment, and pathogenesis. Neurologist. 2006 Sep; 12(5):231-9. PMID: 16990734.
      View in: PubMed
    Puwanant's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description
    Physical Neighbors Expand Description